Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance

INTRODUCTION: Chemotherapy remains the only available treatment for triple-negative (TN) breast cancer, and most patients exhibit an incomplete pathologic response. Half of patients exhibiting an incomplete pathologic response die within five years of treatment due to chemo-resistant, recurrent tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Li, Shenduo, Payne, Sturgis, Wang, Fang, Claus, Peter, Su, Zuowei, Groth, Jeffrey, Geradts, Joseph, de Ridder, Gustaaf, Alvarez, Rebeca, Marcom, Paul Kelly, Pizzo, Salvatore V., Bachelder, Robin E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491247/
https://ncbi.nlm.nih.gov/pubmed/26141457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0590-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados